Compugen
CGEN
42 hedge funds and large institutions have $91.5M invested in Compugen in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 4 closing their positions.
55% more capital invested
Capital invested by funds: $59M → $91.5M (+$32.5M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
9.28% more ownership
Funds ownership: 25.67% → 34.95% (+9.3%)
2% more funds holding
Funds holding: 41 → 42 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
57% less call options, than puts
Call options by funds: $181K | Put options by funds: $425K
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$675K |
| 2 |
Morgan Stanley
New York
|
-$350K |
| 3 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
-$107K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$96.6K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$70K |
CGEN Hedge Fund Activity: Q3 2019 in Review
42 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Compugen (CGEN) for Q3 2019, worth a combined $91.5M — up 55% from $59M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CGEN positions and 4 closed out — a net gain of 1 holder — while 9 added to existing stakes and 15 trimmed.
The largest buyer was Nikko Asset Management Americas, adding an estimated $23.2M. The largest seller was Goldman Sachs, exiting entirely with an estimated $675K sold.
- 42 institutional investors held Compugen (CGEN) as of Q3 2019, up from 41 in Q2 2019.
- Funds reported $91.5M of Compugen stock for Q3 2019, up 55% quarter-over-quarter.
- 5 funds opened new Compugen positions in Q3 2019 and 4 closed out, a net change of +1 holder.
- The largest Compugen buyer in Q3 2019 was Nikko Asset Management Americas, an estimated $23.2M added.
- The largest Compugen seller in Q3 2019 was Goldman Sachs, an estimated $675K sold.
Based on aggregated 13F filings for Q3 2019.